These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12711571)

  • 21. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis.
    Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA
    J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Following the ASCOT Study. A statin for every hypertensive patient?].
    MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391
    [No Abstract]   [Full Text] [Related]  

  • 23. Eating fish linked to fewer heart attacks. One salmon supper a week is all it takes. But a healthy vegetarian diet is just as good for your heart.
    Harv Heart Lett; 2014 Dec; 25(4):4. PubMed ID: 26094259
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of exercise training heart rate in patients on beta-blockers after myocardial infarction.
    Tabet JY; Meurin P; Ben Driss A; Thabut G; Weber H; Renaud N; Odjinkem N; Solal AC
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):538-43. PubMed ID: 16874142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the secondary prevention of coronary heart disease.
    Veverka A; Jolly JL
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):877-89. PubMed ID: 15500433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Secondary prevention of patients with ischaemic heart disease--the reduction of LDL cholesterol level and the regression of atherosclerosis].
    Bárczi G; Merkely B
    Lege Artis Med; 2007 Oct; 17(10):675-9. PubMed ID: 19227597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Better clinical outcome in coronary disease patients with lower level of low-density lipoprotein cholesterol].
    Zhao SP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):865-7. PubMed ID: 16029518
    [No Abstract]   [Full Text] [Related]  

  • 28. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
    Bruckert E; Giral P; Tellier P
    Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
    [No Abstract]   [Full Text] [Related]  

  • 29. Secondary prevention with bezafibrate therapy for the treatment of dyslipidemia: an extended follow-up of the BIP trial.
    Goldenberg I; Benderly M; Goldbourt U;
    J Am Coll Cardiol; 2008 Jan; 51(4):459-65. PubMed ID: 18222357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins for high blood pressure?
    Harv Heart Lett; 2003 Jun; 13(10):7. PubMed ID: 12835152
    [No Abstract]   [Full Text] [Related]  

  • 31. A healing heart. Don't forget diabetes.
    Gottlieb SH
    Diabetes Forecast; 2005 Apr; 58(4):29-30, 32. PubMed ID: 15858896
    [No Abstract]   [Full Text] [Related]  

  • 32. [Statins-a panacea?].
    Klose G
    Z Kardiol; 2004; 93 Suppl 1():I19-22. PubMed ID: 15022003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Step-care approach to hyperlipidemia: guidelines for clinicians.
    Cantwell JD
    J Med Assoc Ga; 1984 Feb; 73(2):107-11. PubMed ID: 6707544
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.
    Liem AH; van Boven AJ; Veeger NJ; Withagen AJ; Robles de Medina RM; Tijssen JG; van Veldhuisen DJ;
    Int J Cardiol; 2004 Feb; 93(2-3):175-9. PubMed ID: 14975544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H;
    Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined endurance/resistance training early on, after a first myocardial infarction, does not induce negative left ventricular remodelling.
    Schmid JP; Anderegg M; Romanens M; Morger C; Noveanu M; Hellige G; Saner H
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):341-6. PubMed ID: 18525391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Clinical Outcomes Utilizing Revascularizaton and Aggressive Drug Evaluation trial: a vindication of the power of medical therapy for the secondary prevention of coronary heart disease.
    Sheikh F; Blumenthal RS; Amsterdam E
    Am J Cardiol; 2007 Dec; 100(12):1808-9. PubMed ID: 18082532
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lower coronary risk with aggressive cholesterol inhibition?].
    Hönl BS
    Med Monatsschr Pharm; 2006 Jun; 29(6):230-1. PubMed ID: 16792204
    [No Abstract]   [Full Text] [Related]  

  • 39. Meet the cholesterol busters.
    Healy B
    US News World Rep; 2004 Mar 22-29; 136(10):54. PubMed ID: 15069903
    [No Abstract]   [Full Text] [Related]  

  • 40. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow-up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial.
    Kang HJ; Kim HS; Koo BK; Kim YJ; Lee D; Sohn DW; Oh BH; Park YB
    Am Heart J; 2007 Feb; 153(2):237.e1-8. PubMed ID: 17239682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.